Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13174873 | 0.91 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL20643406 | 0.87 | — | — | |
| SCHEMBL19168756 | 0.87 | — | — | |
| SCHEMBL12972450 | 0.81 | ALDH1A1 (0.47) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL18532308 | 0.76 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL3366291 | 0.73 | — | — | |
| SCHEMBL1093910 | 0.73 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL21860393 | 0.73 | METAP1 (0.40) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL21091974 | 0.73 | — | — | |
| SCHEMBL24269491 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11046798-B2 | Phosphono-phosphate containing compounds and polymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-06-29 | — | — | US | disclosed |
| EP-3183363-B1 | METHOD FOR DETERMINING THE SURVIVAL PROGNOSIS OF A PATIENT SUFFERING FROM PANCREATIC CANCER | ACOBIOM (FR) | 2020-03-18 | — | — | EP | disclosed |
| US-20190192674-A1 | NUCLEIC ACID CONJUGATE | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| US-20190177456-A1 | Phosphono-Phosphate Containing Compounds And Polymers | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177456-A1 | Phosphono-Phosphate Containing Compounds And Polymers | PHPT1, PHOSPHO1, PPIP5K2 | ALDH1A1 4857/4885TSHR 4020/4885MAPK1 2830/4885 |
| US-20190192674-A1 | NUCLEIC ACID CONJUGATE | M6PR, NSUN2, NSUN3 | ALDH1A1 1171/4885TSHR 1386/4885MAPK1 1494/4885 |
| US-11046798-B2 | Phosphono-phosphate containing compounds and polymers | PHPT1, PHOSPHO1, PPIP5K2 | ALDH1A1 4857/4885TSHR 4020/4885MAPK1 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.